Covaris has appointed Annemarie Watson as CEO. She replaces company founder Jim Laugharn, who will continue to serve on the board of directors. Laugharn will also assume the role of chief technology officer.

Watson previously served as SVP of clinical diagnostics at Eurofins Scientific.

“I am grateful to have been given the opportunity to lead Covaris, a leader in the life sciences industry with a strong culture of innovation,” Watson said in a statement. “I  look forward to working with our team and our partners at New Mountain Capital to expand our capabilities, help bring our technology to more customers and continue to cement our place as the preeminent sample prep platform for multiple discovery and analytical workflows.”